The speaker for this new event in memory of Anne Örtegren at the 13th International Invest in ME Research Conference in London on 1st June 2018, is Professor Theoharis C. Theoharides, Professor of Pharmacology and Internal Medicine at the Director of Molecular Immunopharmacology and Drug Discovery, Department of Immunology at Tufts University School of Medicine, Boston in USA. He will also be participating in the 8th International Biomedical Research into ME Colloquium over the two days prior.
Professor Theoharides first showed that mast cells, known for causing allergic reactions, are critical for inflammation, especially in the brain, and are involved in a number of inflammatory conditions that worsen by stress such as allergies, asthma, chronic fatigue syndrome, eczema, fibromyalgia, migraines, mastocytosis, multiple sclerosis, psoriasis, and most recently autism spectrum disorder. More here: http://www.investinme.eu/IIMEC13-news-180202.shtml
Anne had once written to the charity that she would love to see a mast cell researcher present at the colloquium and perhaps presenting at the conference and they have fulfilled their last promise to Anne to try to make this happen.

Professor Theoharides first showed that mast cells, known for causing allergic reactions, are critical for inflammation, especially in the brain, and are involved in a number of inflammatory conditions that worsen by stress such as allergies, asthma, chronic fatigue syndrome, eczema, fibromyalgia, migraines, mastocytosis, multiple sclerosis, psoriasis, and most recently autism spectrum disorder. More here: http://www.investinme.eu/IIMEC13-news-180202.shtml
Anne had once written to the charity that she would love to see a mast cell researcher present at the colloquium and perhaps presenting at the conference and they have fulfilled their last promise to Anne to try to make this happen.
Anne was a vital link in helping us to build international collaboration, especially in Sweden, her homeland.
Her support and friendship to us, and many others, was an example of resilience, determination, kindness and modesty.
Anne represented the very best of ME advocacy - despite the incredible suffering she experienced.
There is little that we can do other than to continue to campaign for proper research into ME - and to find, fund and facilitate biomedical research which will lead to the uncovering of the cause(s) of ME and to development of treatments for the disease.
But the charity has decided to recognise the work of Anne by devoting a dedicated presentation slot in our conference programme.
http://www.investinme.eu/IIMEC13-news-180201.shtml
